D L. Tyrrell

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity.

Interferon-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity.

Journal: Nature communications
Published: April 29, 2022

Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19.

Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19.

Journal: BMC pharmacology & toxicology
Published: April 08, 2021

Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Journal: Nature communications
Published: October 21, 2020

Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2.

Interferons and viruses induce a novel primate-specific isoform dACE2 and not the SARS-CoV-2 receptor ACE2.

Journal: bioRxiv : the preprint server for biology
Published: August 04, 2020

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.

Journal: Nature communications
Published: April 29, 2020

Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs.

Sociodemographic risk factors for hepatitis C virus infection in a prospective cohort study of 257 persons in Canada who inject drugs.

Journal: Canadian liver journal
Published: August 18, 2019

Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs.

Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs.

Journal: Journal of substance abuse treatment
Published: July 17, 2018

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.

Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer.

Journal: Frontiers in immunology
Published: June 21, 2017

A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression.

A novel method for detection of IFN-lambda 3 binding to cells for quantifying IFN-lambda receptor expression.

Journal: Journal of immunological methods
Published: January 07, 2017

Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.

Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.

Journal: Journal of virology
Published: August 05, 2016

Highly bioavailable silibinin nanoparticles inhibit HCV infection.

Highly bioavailable silibinin nanoparticles inhibit HCV infection.

Journal: Gut
Published: April 07, 2016

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.

Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome.

Journal: Cytokine
Published: August 13, 2015
Showing 1-12 of 25

Last Updated: 09/26/2026